Trademark: 88361384
Word
ENZYVANT
Status
Registered
Status Code
700
Status Date
Tuesday, June 16, 2020
Serial Number
88361384
Registration Number
6077704
Registration Date
Tuesday, June 16, 2020
Mark Type
4000
Filing Date
Thursday, March 28, 2019
Published for Opposition
Tuesday, March 31, 2020

Trademark Owner History
Enzyvant Therapeutics GmbH - Original Registrant

Classifications
5 Pharmaceutical preparations for human use for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto
42 Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market clinical trials
44 (Based on 44(e)) Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions

Trademark Events
Jun 16, 2020
Registered-Principal Register
Mar 31, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 31, 2020
Published For Opposition
Mar 11, 2020
Notification Of Notice Of Publication E-Mailed
Feb 27, 2020
Electronic Record Review Complete
Feb 7, 2020
On Hold - Electronic Record Review Required
Feb 4, 2020
Approved For Pub - Principal Register
Jan 27, 2020
Teas/Email Correspondence Entered
Jan 26, 2020
Correspondence Received In Law Office
Jan 26, 2020
Teas Request For Reconsideration Received
Jan 25, 2020
Notification Of Final Refusal Emailed
Jan 25, 2020
Final Refusal E-Mailed
Jan 25, 2020
Final Refusal Written
Nov 14, 2019
Teas/Email Correspondence Entered
Nov 13, 2019
Correspondence Received In Law Office
Nov 13, 2019
Teas Response To Office Action Received
Jul 25, 2019
Assigned To Examiner
May 18, 2019
Notification Of Non-Final Action E-Mailed
May 18, 2019
Non-Final Action E-Mailed
May 18, 2019
Non-Final Action Written
May 9, 2019
Assigned To Examiner
Apr 16, 2019
New Application Office Supplied Data Entered In Tram
Apr 1, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24